Abstract:BACKGROUND:Copy number alterations (CNA) and loss of heterozygosity (LOH) represent a large proportion of genetic structural variations of cancer genomes. These aberrations are continuously accumulated during the procedure of clonal evolution and patterned by phylogenetic branching. This invariably results in the emergence of multiple cell populations with distinct complement of mutational landscapes in tumor sample. With the advent of next-generation sequencing technology, inference of subclonal populations has become one of the focused interests in cancer-associated studies, and is usually based on the assessment of combinations of somatic single-nucleotide variations (SNV), CNA and LOH. However, cancer samples often have several inherent issues, such as contamination of normal stroma, tumor aneuploidy and intra-tumor heterogeneity. Addressing these critical issues is imperative for accurate profiling of clonal architecture.METHODS:We present CLImAT-HET, a computational method designed for capturing clonal diversity in the CNA/LOH dimensions by taking into account the intra-tumor heterogeneity issue, in the case where a reference or matched normal sample is absent. The algorithm quantitatively represents the clonal identification problem using a factorial hidden Markov model, and takes an integrated analysis of read counts and allele frequency data. It is able to infer subclonal CNA and LOH events as well as the fraction of cells harboring each event.RESULTS:The results on simulated datasets indicate that CLImAT-HET has high power to identify CNA/LOH segments, it achieves an average accuracy of 0.87. It can also accurately infer proportion of each clonal population with an overall Pearson correlation coefficient of 0.99 and a mean absolute error of 0.02. CLImAT-HET shows significant advantages when compared with other existing methods. Application of CLImAT-HET to 5 primary triple negative breast cancer samples demonstrates its ability to capture clonal diversity in the CAN/LOH dimensions. It detects two clonal populations in one sample, and three clonal populations in one other sample.CONCLUSIONS:CLImAT-HET, a novel algorithm is introduced to infer CNA/LOH segments from heterogeneous tumor samples. We demonstrate CLImAT-HET's ability to accurately recover clonal compositions using tumor WGS data without a match normal sample.

HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data

Clonecna: Detecting Subclonal Somatic Copy Number Alterations in Heterogeneous Tumor Samples from Whole-Exome Sequencing Data

CLImAT-HET: Detecting Subclonal Copy Number Alterations and Loss of Heterozygosity in Heterogeneous Tumor Samples from Whole-Genome Sequencing Data.

HaplotypeCN: Copy Number Haplotype Inference with Hidden Markov Model and Localized Haplotype Clustering

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Accucopy: accurate and fast inference of allele-specific copy number alterations from low-coverage low-purity tumor sequencing data

Robust analysis of allele-specific copy number alterations from scRNA-seq data with XClone

Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes

SiCloneFit: Bayesian inference of population structure, genotype, and phylogeny of tumor clones from single-cell genome sequencing data

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

scGAL: unmask tumor clonal substructure by jointly analyzing independent single-cell copy number and scRNA-seq data

Major Copy Proportion Analysis of Tumor Samples Using Snp Arrays

SCONCE: a method for profiling copy number alterations in cancer evolution using single-cell whole genome sequencing

Inferring allele-specific copy number aberrations and tumor phylogeography from spatially resolved transcriptomics

A statistical learning method for simultaneous copy number estimation and subclone clustering with single-cell sequencing data

Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc

BIC-seq: a Fast Algorithm for Detection of Copy Number Alterations Based on High-Throughput Sequencing Data

Refphase: Multi-sample phasing reveals haplotype-specific copy number heterogeneity

Sensitive detection of copy number alterations in samples with low circulating tumor DNA fraction

Abstract 1205: Inferring allele-specific copy number aberrations and tumor phylogeography from spatially resolved transcriptomics

High resolution copy number inference in cancer using short-molecule nanopore sequencing